---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-011757"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2026-04-08T23:59:59+00:00"
generated_at: "2026-05-15T06:57:43.614596+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ImmuCell reports Q1 2026 preliminary sales up 28.4% to $10.4M; Tri-Shield up 38.5%

## Summary
- Total product sales $10.4M vs $8.1M in Q1 2025, a 28.4% increase.
- Domestic sales $9.7M (+35.7%); international sales $0.6M (-30.2%).
- Tri-Shield First Defense sales $7.9M (+38.5%); Dual-Force & Other $2.5M (+4.4%).
- CFO notes prior backorder situation still complicates comparisons but operational progress shown.
- Conference call scheduled for May 15, 2026 at 9:00 AM ET.

## SEC filing metadata
- accession: 0001437749-26-011757
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2026-04-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000143774926011757/0001437749-26-011757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000143774926011757/iccc20260408_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-011757
- JSON: https://secwatch.observer/filing/0001437749-26-011757.json
- Plain text: https://secwatch.observer/filing/0001437749-26-011757.txt

## Key facts
- Earnings Releases
  IMMUCELL CORP /DE/ reported the quarter ended March 31, 2026 results: revenue $10.4 million.
  - Period: the quarter ended March 31, 2026
  - Revenue: $10.4 million
  - Result: preliminary results
  source text: health and productivity, today announced preliminary, unaudited sales results for the first quarter of 2026. Total sales for the three-month period ended March 31, 2026 were $10.4 million, a 28.4% increase compared to the three-month period ended March 31, 2025. For the three-month period ended March 31: ● Domestic sales were $9.7 million in 2026, a 35.7% increase
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000143774926011757/0001437749-26-011757-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.